Our Pricing

Complete Mounjaro Dosing Chart: UK Dose Escalation Guide

The mounjaro dosing chart provides essential guidance for patients starting tirzepatide treatment in the UK, outlining the structured dose escalation from 2.5mg to 15mg over several months. Understanding this dosing schedule is critical for achieving optimal weight loss results whilst minimising gastrointestinal side effects. At Cured Pharmacy, we provide Mounjaro from £124.99 with full clinical support and transparent dosing guidance, ensuring every patient receives expert advice tailored to their treatment journey.

Understanding the Mounjaro Dosing Chart Structure

The mounjaro dosing chart follows a carefully designed escalation protocol that begins with a 2.5mg subcutaneous injection once weekly for the first four weeks [1]. This starting dose serves as an initiation phase, allowing your body to adapt to tirzepatide's dual GIP and GLP-1 receptor agonist activity whilst minimising common side effects such as nausea and reduced appetite. The structured approach differs significantly from other weight loss medications, as tirzepatide requires gradual upward titration to reach therapeutic doses.

Following the initial month, the mounjaro dosing chart progresses to 5mg weekly for four weeks, then 7.5mg, 10mg, 12.5mg, and finally 15mg if additional weight loss is needed [2]. Each dose increase occurs at four-week intervals, giving your body sufficient time to adjust to the medication's effects on glucose regulation and appetite suppression. Clinical trials demonstrated that patients who followed this escalation schedule experienced up to 22.5% body weight reduction over 72 weeks, with the highest efficacy observed at the 10mg and 15mg maintenance doses [1].

At Cured Pharmacy, our UK-registered clinical team ensures every patient receives a personalised mounjaro dosing chart aligned with MHRA-approved prescribing guidelines. Your treatment plan includes detailed instructions for each dose escalation, injection technique guidance, and ongoing monitoring to assess tolerability and efficacy. All Mounjaro prescriptions require clinical assessment by a UK prescriber, ensuring safe and appropriate use throughout your weight loss journey.

Mounjaro Dosing Chart: Starting Dose and Initiation Phase

The mounjaro dosing chart always begins with the 2.5mg starting dose, administered subcutaneously once weekly for four consecutive weeks. This initiation dose is not intended to produce significant weight loss but rather to establish tolerability and allow your gastrointestinal system to adapt to tirzepatide's mechanism of action [2]. During this phase, patients commonly report mild nausea, reduced appetite, and occasional digestive changes, which typically resolve as treatment continues.

Research from the SURPASS-2 trial demonstrated that gradual dose escalation, as outlined in the mounjaro dosing chart, significantly reduced the incidence of severe gastrointestinal adverse events compared to more rapid titration schedules [3]. The 2.5mg starting dose activates both GIP and GLP-1 receptors at a level sufficient to initiate metabolic changes without overwhelming the body's adaptive capacity. This approach reflects current best practice in incretin-based therapy, prioritising patient comfort and treatment adherence over rapid weight loss.

At Cured Pharmacy, we provide comprehensive support during the initiation phase, including dietary guidance and side effect management strategies. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures every patient understands the importance of following the mounjaro dosing chart precisely, as skipping the starting dose or escalating too quickly can increase the risk of treatment discontinuation due to intolerable side effects.

What to Expect During Your First Month on Mounjaro

During the first four weeks at the 2.5mg starting dose outlined in the mounjaro dosing chart, most patients experience modest appetite reduction and gradual changes in eating behaviour. Weight loss during this phase typically ranges from 1-3kg, though individual responses vary considerably based on baseline weight, dietary habits, and metabolic factors [2]. The primary goal remains establishing tolerability rather than achieving maximal weight loss, which occurs at higher maintenance doses later in the treatment schedule.

Mounjaro Dosing Chart: Dose Escalation Schedule Explained

The mounjaro dosing chart prescribes a systematic escalation pattern: 2.5mg for four weeks, then 5mg for four weeks, followed by 7.5mg, 10mg, 12.5mg, and finally 15mg if needed [1]. Each four-week interval allows sufficient time for your body to adapt to the increased tirzepatide exposure whilst monitoring for efficacy and tolerability. This gradual approach maximises treatment adherence, as studies show that patients who follow the recommended escalation schedule are significantly more likely to reach therapeutic doses and achieve clinically meaningful weight loss.

Clinical data from the SURMOUNT-1 trial revealed that 89% of participants reached the 10mg or 15mg maintenance doses when following the standard mounjaro dosing chart, compared to only 67% in cohorts with accelerated titration [3]. The four-week intervals are not arbitrary—they reflect the pharmacokinetic profile of tirzepatide, which reaches steady-state concentrations after approximately four weeks of consistent weekly dosing. Increasing the dose before steady state is achieved can lead to unpredictable plasma levels and increased side effect burden.

At Cured Pharmacy, we monitor your progress at each dose level, adjusting the mounjaro dosing chart if you experience persistent side effects or require additional time at a particular dose. Some patients achieve their weight loss goals at the 7.5mg or 10mg dose and do not require further escalation to 12.5mg or 15mg. Your UK prescriber will review your response at regular intervals, ensuring your treatment plan remains aligned with both clinical guidelines and your individual tolerance.

When to Increase Your Mounjaro Dose

The mounjaro dosing chart specifies dose increases every four weeks, provided you tolerate the current dose without severe side effects. If you experience persistent nausea, vomiting, or other gastrointestinal symptoms that interfere with daily activities, your prescriber may recommend remaining at your current dose for an additional four weeks before escalating. This flexibility ensures treatment remains sustainable and comfortable, as premature escalation often leads to treatment discontinuation [2].

Mounjaro Dosing Chart: Maintenance Doses and Long-Term Use

The mounjaro dosing chart identifies 10mg and 15mg as the primary maintenance doses for long-term weight management, with most patients achieving optimal results at these levels [1]. Clinical trials demonstrated that the 10mg dose produced an average weight loss of 19.5% over 72 weeks, whilst the 15mg dose achieved 22.5% reduction in body weight among participants with obesity [3]. Once you reach your maintenance dose, you continue weekly injections at that level for the duration of your treatment, which may extend for months or years depending on your weight loss goals and clinical response.

The mounjaro dosing chart does not include a tapering or discontinuation schedule, as tirzepatide is intended for chronic weight management rather than short-term use. Research indicates that weight regain commonly occurs after stopping treatment, with patients regaining an average of 14% of their body weight within one year of discontinuation [2]. For this reason, UK prescribers typically recommend ongoing treatment at the lowest effective maintenance dose that sustains your weight loss, balanced against cost considerations and long-term tolerability.

At Cured Pharmacy, we provide Mounjaro maintenance doses from £124.99 with transparent pricing and no hidden fees. Our clinical team conducts regular reviews to assess whether your current maintenance dose remains appropriate or whether dose adjustment is warranted based on your weight trajectory, side effect profile, and overall treatment satisfaction. All adjustments to your mounjaro dosing chart require prescriber approval and are documented in your clinical record.

Mounjaro Dosing Chart Compared to Other Weight Loss Treatments

The mounjaro dosing chart differs substantially from other injectable weight loss medications available in the UK, particularly in its dose range and escalation timeline. Wegovy (semaglutide) follows a shorter escalation schedule, reaching its maximum 2.4mg dose within 16 weeks, whilst Saxenda (liraglutide) escalates daily from 0.6mg to 3mg over five weeks [4]. Mounjaro's extended escalation to 15mg over 24 weeks reflects tirzepatide's dual receptor mechanism and higher potency, requiring more gradual titration to maintain tolerability.

Comparative trials have demonstrated that the mounjaro dosing chart, when followed to the 10mg or 15mg maintenance dose, produces superior weight loss outcomes compared to semaglutide 2.4mg. The SURPASS-2 head-to-head trial showed that tirzepatide 10mg and 15mg resulted in 7.6kg and 9.3kg greater weight loss respectively than semaglutide 1mg over 40 weeks [3]. Whilst direct comparison data against Wegovy's 2.4mg dose remains limited, indirect evidence suggests tirzepatide's dual incretin action provides enhanced efficacy at therapeutic doses.

At Cured Pharmacy, we offer both Mounjaro and alternative weight loss treatments, allowing our clinical team to recommend the most appropriate option based on your medical history, weight loss goals, and budget. The mounjaro dosing chart requires a longer commitment to reach maintenance doses, but many patients find the superior efficacy justifies the extended escalation period. All treatment decisions are made collaboratively with your UK prescriber during your online consultation.

Choosing Between Mounjaro and Wegovy Dosing Schedules

When comparing the mounjaro dosing chart to Wegovy's escalation schedule, consider that Mounjaro requires 24 weeks to reach the maximum 15mg dose, whilst Wegovy reaches 2.4mg in 16 weeks. Patients seeking faster dose escalation may prefer Wegovy, whilst those prioritising maximal weight loss efficacy often benefit from following the mounjaro dosing chart to the higher maintenance doses. Your UK prescriber will help determine which treatment schedule aligns best with your clinical profile and expectations.

Following Your Mounjaro Dosing Chart Safely: UK Prescribing Guidelines

Adherence to the mounjaro dosing chart is essential for safe and effective treatment, as deviations from the recommended escalation schedule can increase side effect risk and reduce treatment efficacy. The MHRA-approved prescribing information specifies that dose increases should only occur at four-week intervals, and patients should never self-escalate without prescriber guidance [1]. Skipping doses or irregular administration disrupts steady-state plasma concentrations, potentially leading to breakthrough side effects or diminished weight loss response.

The mounjaro dosing chart also includes guidance for managing missed doses: if you miss your weekly injection and fewer than four days have passed, administer the dose as soon as possible. If more than four days have elapsed, skip the missed dose and resume your regular schedule with the next planned injection [2]. Never double your dose to compensate for a missed injection, as this significantly increases the risk of severe nausea, vomiting, and gastrointestinal distress.

At Cured Pharmacy, our UK-registered clinical team provides detailed written instructions accompanying your mounjaro dosing chart, including injection technique guidance, storage requirements, and side effect management protocols. We maintain ongoing communication throughout your treatment, ensuring you have access to professional support if questions or concerns arise. All Mounjaro prescriptions are subject to clinical assessment and ongoing monitoring by UK prescribers, in full compliance with MHRA regulations and GPhC standards.

What to Do If You Experience Side Effects During Dose Escalation

If you experience persistent or severe side effects during any phase of the mounjaro dosing chart, contact your prescriber before proceeding to the next dose increase. Common strategies include remaining at your current dose for an additional four weeks, temporarily reducing to the previous dose, or implementing dietary modifications to improve tolerability [2]. Never discontinue Mounjaro abruptly without prescriber guidance, as gradual dose reduction may be recommended in some cases to minimise withdrawal effects and weight regain.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515.
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycemic control and body weight in obesity: SURMOUNT-1 extension study. Diabetes Care, 46(4), 788-799.
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.